ArticleCell reports. Medicine2025
Deep learning for detection and diagnosis of intrathoracic lymphadenopathy from endobronchial ultrasound multimodal videos: A multi-center study.
Article in Cell reports. Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Deep learning-derived left ventricular circumferential strain for cardiac MRI diagnosis of acute myocarditis with preserved ejection fraction.The international journal of cardiovascular imaging · 2026Article
- Annual progress in transbronchial diagnosis and treatment of pulmonary malignant tumors [2025]: a narrative review.Translational lung cancer research · 2026Review
- Applications of Artificial Intelligence in Endobronchial Ultrasound for Lung Cancer Diagnosis and Staging: A Scoping Review.Current oncology (Toronto, Ont.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Convex probe endobronchial ultrasound (CP-EBUS) ultrasonographic features are important for diagnosing intrathoracic lymphadenopathy. Conventional methods for CP-EBUS imaging analysis rely heavily on physician expertise. To overcome this obstacle, we propose a deep learning-aided diagnostic system (AI-CEMA) to automatically select representative images, identify lymph nodes (LNs), and differentiate benign from malignant LNs based on CP-EBUS multimodal videos. AI-CEMA is first trained using 1,006 LNs from a single center and validated with a retrospective study and then demonstrated with a prospective multi-center study on 267 LNs. AI-CEMA achieves an area under the curve (AUC) of 0.8490 (95% confidence interval [CI], 0.8000-0.8980), which is comparable to experienced experts (AUC, 0.7847 [95% CI, 0.7320-0.8373]; p = 0.080). Additionally, AI-CEMA is successfully transferred to a pulmonary lesion diagnosis task and obtains a commendable AUC of 0.8192 (95% CI, 0.7676-0.8709). In conclusion, AI-CEMA shows great potential in clinical diagnosis of intrathoracic lymphadenopathy and pulmonary lesions by providing automated, noninvasive, and expert-level diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.